These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9056005)
21. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128 [TBL] [Abstract][Full Text] [Related]
22. Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniae. Patel KB; Nicolau DP; Nightingale CH; Quintiliani R Antimicrob Agents Chemother; 1996 Dec; 40(12):2805-8. PubMed ID: 9124845 [TBL] [Abstract][Full Text] [Related]
23. Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics. Heseltine PN; Appleman MD; Leedom JM Rev Infect Dis; 1984; 6 Suppl 1():S254-9. PubMed ID: 6585882 [TBL] [Abstract][Full Text] [Related]
24. Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus. Baxter R; Chapman J; Drew WL J Infect Dis; 1990 May; 161(5):1023-5. PubMed ID: 2324530 [TBL] [Abstract][Full Text] [Related]
25. Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae. Lacy MK; Owens RC; Xu X; Nicolau DP; Quintiliani R; Nightingale CH Int J Antimicrob Agents; 1998 Nov; 10(4):279-83. PubMed ID: 9916901 [TBL] [Abstract][Full Text] [Related]
26. Comparative serum bactericidal activity of ceftizoxime/metronidazole, ceftizoxime, clindamycin, and imipenem against obligate anaerobic bacteria. Kowalsky SF; Echols RM; McCormick EM J Antimicrob Chemother; 1990 May; 25(5):767-75. PubMed ID: 2373663 [TBL] [Abstract][Full Text] [Related]
27. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates. Oteo J; Aracil B; Alós JI; Gómez-Garcés JL J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095 [TBL] [Abstract][Full Text] [Related]
28. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Lepak AJ; Andes DR Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam. Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201 [TBL] [Abstract][Full Text] [Related]
31. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria. Jokipii AM; Jokipii L Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974 [TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect. Boswell FJ; Andrews JM; Wise R J Antimicrob Chemother; 1998 Feb; 41(2):149-53. PubMed ID: 9533455 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group. Stratton CW; Weeks LS; Aldridge KE Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole. Agudelo M; Vesga O Antimicrob Agents Chemother; 2012 May; 56(5):2659-65. PubMed ID: 22330928 [TBL] [Abstract][Full Text] [Related]
35. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli. Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702 [TBL] [Abstract][Full Text] [Related]
36. Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Ralph ED; Kirby WM Antimicrob Agents Chemother; 1975 Oct; 8(4):409-14. PubMed ID: 172007 [TBL] [Abstract][Full Text] [Related]
37. Bactericidal activity of the combinations of gentamicin with clindamycin or chloramphenicol against species of Escherichia coli and Bacteroides fragilis. Klastersky J; Husson M Antimicrob Agents Chemother; 1977 Aug; 12(2):135-8. PubMed ID: 332070 [TBL] [Abstract][Full Text] [Related]